Armonair Respiclick FDA Approved Drugs
ARMONAIR RESPICLICK [Fluticasone PropionateC25H31F3O5S]
RX
- 0.055mg/inh (inhalation powder)
0.113mg/inh (inhalation powder)
0.232mg/inh (inhalation powder)
Teva PharmJan 27, 2017
CUTIVATE [Fluticasone PropionateC25H31F3O5S]
RX
- 0.005% (topical ointment)
0.05% (topical lotion)
Fougera PharmsDec 14, 1990
FLONASE ALLERGY RELIEF [Fluticasone PropionateC25H31F3O5S]
OTC
- 0.05mg/spray (nasal spray, metered)
Glaxosmithkline ConsJul 23, 2014
FLOVENT DISKUS 100 [Fluticasone PropionateC25H31F3O5S]
RX
- 0.1mg/inh (inhalation powder)
Glaxo Grp LtdSep 29, 2000
FLOVENT DISKUS 250 [Fluticasone PropionateC25H31F3O5S]
RX
- 0.25mg/inh (inhalation powder)
Glaxo Grp LtdSep 29, 2000
FLOVENT DISKUS 50 [Fluticasone PropionateC25H31F3O5S]
RX
- 0.05mg/inh (inhalation powder)
Glaxo Grp LtdSep 29, 2000
FLOVENT HFA [Fluticasone PropionateC25H31F3O5S]
RX
- 0.044mg/inh (inhalation aerosol, metered)
0.11mg/inh (inhalation aerosol, metered)
0.22mg/inh (inhalation aerosol, metered)
Glaxo Grp LtdMay 14, 2004
- Method of treating a condition capable of treatment by inhalation, e.g. asthma, comprising administration of a formulation claimed in us patent no. 6743413.
FLUTICASONE PROPIONATE [Fluticasone PropionateC25H31F3O5S]
RX / OTC
- 0.005% (topical ointment)
0.05% (topical cream)
0.05mg/spray (nasal spray, metered)
Fougera PharmsMay 14, 2004
G And W LabsMar 3, 2006
Perrigo New YorkMay 14, 2004
Glenmark GenericsMay 2, 2011
Perrigo IsraelJul 30, 2013
TolmarMay 14, 2004
Apotex IncFeb 29, 2016
Hi Tech PharmaJan 16, 2008
West-ward Pharms IntFeb 22, 2006
WockhardtJan 9, 2012
G And W LabsMar 3, 2006
Perrigo New YorkMay 14, 2004
Glenmark GenericsMay 2, 2011
Perrigo IsraelJul 30, 2013
TolmarMay 14, 2004
Apotex IncFeb 29, 2016
Hi Tech PharmaJan 16, 2008
West-ward Pharms IntFeb 22, 2006
WockhardtJan 9, 2012
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.